Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of mitochondria in the resistance of melanoma to PD-1 inhibitors
Fei Du, Lu-han Yang, Jiao Liu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 22

Showing 22 citing articles:

Cuproptosis: unveiling a new frontier in cancer biology and therapeutics
Ying Feng, Zhibo Yang, Jianpeng Wang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 18
Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer
Carmine Rocca, Teresa Soda, Ernestina Marianna De Francesco, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 33
“Reinforcement” by Tumor Microenvironment: The Seventh “R” of Radiobiology
Farzad Taghizadeh‐Hesary
International Journal of Radiation Oncology*Biology*Physics (2023) Vol. 119, Iss. 3, pp. 727-733
Closed Access | Times Cited: 25
Advances in Immunotherapy for Hepatocellular Carcinoma (HCC)
Fuat Bicer, Catrina Kure, Anil A. Ozluk, et al.
Current Oncology (2023) Vol. 30, Iss. 11, pp. 9789-9812
Open Access | Times Cited: 17
Targeting novel regulated cell death: disulfidptosis in cancer immunotherapy with immune checkpoint inhibitors
Fei Du, Guojun Wang, Qian Dai, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Identification of Marker Genes and Immune Characterization of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma
博林 李
Advances in Clinical Medicine (2025) Vol. 15, Iss. 02, pp. 1111-1120
Closed Access
Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity
Roberta Torcasio, Maria Eugenia Gallo Cantafio, Claudia Veneziano, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Deciphering and overcoming Anti-PD-1 resistance in Melanoma: A comprehensive review of Mechanisms, biomarker Developments, and therapeutic strategies
Ruoqi Wang, Yanbin Chen, Yongyi Xie, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111989-111989
Closed Access | Times Cited: 4
A new era in melanoma immunotherapy: focus on DCs metabolic reprogramming
Mina Afrashteh Nour, Mansour Rajabivahid, Marjan Sadat Seyed Mehdi, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Exercise sensitizes PD-1/PD-L1 immunotherapy as a hypoxia modulator in the tumor microenvironment of melanoma
Huiyu Yan, Aimin Jiang, Yinong Huang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Molecular mechanism of specific HLA-A mRNA recognition by the RNA-binding-protein hMEX3B to promote tumor immune escape
Kanglong Yang, Guanglin Chen, Fan Yu, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 2
A critical review on exploring tumor Microenvironment's impacts on radioresistance
Mohammad Houshyari
Journal of Radiation Research and Applied Sciences (2024) Vol. 17, Iss. 2, pp. 100937-100937
Open Access | Times Cited: 2
ROS-producing nanomaterial engineered from Cu(I) complexes with P2N2-ligands for cancer cells treating
Bulat A. Faizullin, Irina R. Dayanova, Alexey V. Kurenkov, et al.
Discover Nano (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 6
Proteomic Analysis Highlights the Impact of the Sphingolipid Metabolizing Enzyme β-Galactosylceramidase on Mitochondrial Plasticity in Human Melanoma
Davide Capoferri, Luca Mignani, Marcello Manfredi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 3062-3062
Open Access | Times Cited: 1
Dihydroartemisinin inhibits liver cancer cell migration and invasion by reducing ATP synthase production through CaMKK2/NCLX
Jiang Chang, Chengyi Xin, Yong Wang, et al.
Oncology Letters (2023) Vol. 26, Iss. 6
Open Access | Times Cited: 3
Mitochondrial Signatures Shape Phenotype Switching and Apoptosis in Response to PLK1 and RSK Inhibitors in Melanoma
Émilie Lavallée, Maëline Roulet-Matton, Viviane Giang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Effects of PD-L1 Inhibitors on Mitochondrial Function in Melanoma A375 Cells: Unveiling a Shielded Drug Resistance Mechanism
宁 张, Fenglan Feng, Ruonan Dang, et al.
Research Square (Research Square) (2024)
Open Access
Melanoma Metabolism: Molecular Mechanisms and Therapeutic Implications in Cutaneous Oncology
Isabella J. Tan, Aarushi K. Parikh, Bernard A. Cohen
Cancer Medicine (2024) Vol. 13, Iss. 21
Open Access
Targeting Mitochondria in Cancer Immunotherapy: Promises and Pitfalls
Pantea Allami, Samin Mortaheb, Ava Aghakhani, et al.
Interdisciplinary cancer research (2024)
Closed Access
Mitochondrial signatures shape phenotype switching and apoptosis in response to PLK1 inhibitors
Émilie Lavallée, Maëline Roulet-Matton, Viviane Giang, et al.
Life Science Alliance (2024) Vol. 8, Iss. 3, pp. e202402912-e202402912
Open Access
Exploring the relationship between total serum calcium and melanoma development: a cross-sectional study
Qiaochu Zhou, Wei Wang, Jinhui Wang, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access
Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial
Zuzana Bielčiková, Lukáš Werner, Jan Štursa, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 1
Stratification of metastatic melanoma patients based on mutational signatures
Caterina Alfano, Lorenzo Farina, Manuela Petti
2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) (2023), pp. 2798-2802
Open Access
Page 1

Scroll to top